NEW YORK (GenomeWeb News) – The UK’s Wellcome Trust said this week that it has awarded £1.3 million ($2.7 million) to support a large genome-wide association study with the goal of understanding the genetic basis of late-onset Alzheimer's disease.

 

Cardiff University will lead the project, which will analyze DNA samples from 14,000 people -- 6,000 with late-onset Alzheimer's disease and 8,000 controls from the UK and US.